YOLFTbeta
Equasens

Equasens

0R9T · LSE

27.60EUR-0.05 (-0.18%)

Price History

Full chart

Market Stats

Previous Close27.65
Open28.10
Day Range27.60 – 28.10
52-Week Range28.70 – 43.34
Volume1
Market Cap580.54M
P/E (TTM)0.12
Forward P/E0.00
EPS2.58
Dividend Yield2.60%
Beta0.56
50-Day Avg52.42
200-Day Avg67.12

About

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; after-sales services, and telephone support and maintenance; and data backup, intermediation, and vocational training services. It also provides medical remote monitoring systems, develops a structured medical speech recognition solution, and designs and manufactures connected electronic devices and equipment, as well as offers interoperability solutions. In addition, the company offers financing platform to facilitate multi-donor management, and financing solutions for leased assets for healthcare professionals and others. It serves healthcare facilities and healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.

Company Details

  • CEOMr. Denis Supplisson
  • Employees1.46K
  • Headquarters5 Allée de Saint-Cloud, Villers-lès-Nancy, France, 54600, UK
  • Websitehttps://equasens.com

Leadership

  • Mr. Denis SupplissonCEO & Director · b. 1969
  • Mr. Grégoire De RotalierDeputy CEO, Deputy MD, Director of Healthcare, Medical & Social Software Division and Director · b. 1970
  • Mr. Dominique PautratChairman of the Board · b. 1965
  • Ms. Frederique SchmidtGroup Chief Administrative & Financial Officer
  • Ms. Noelle StouligHead of Communications
  • Ms. Sabrina GharbiChief Human Resources Officer
  • Mr. Dominique GoursaudHead of the Medical Solutions Division
  • Mr. Francois-Pierre MarquierDeputy CEO, Director of Pharmagest Division & Director

Financials

Income Statement

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue60.67M63.62M67.36M70.95M74.80M81.62M91.55M97.06M108.72M113.41M114.56M113.48M128.38M129.67M148.48M158.57M171.75M193.07M214.07M219.79M216.75M236.57M
Growth (%)-+4.86%+5.88%+5.33%+5.43%+9.12%+12.17%+6.02%+12.01%+4.31%+1.02%-0.95%+13.13%+1.00%+14.51%+6.79%+8.31%+12.41%+10.88%+2.67%-1.38%+9.14%
Cost of Revenue49.63M51.23M54.73M57.63M59.08M65.14M72.03M77.97M86.93M88.63M86.87M79.50M90.48M92.33M106.47M114.08M122.32M139.26M155.07M163.13M169.62M186.84M
Gross Profit11.04M12.39M12.63M13.32M15.72M16.48M19.52M19.09M21.79M24.78M27.69M33.98M37.90M37.34M42.01M44.49M49.44M53.81M59.01M56.66M47.13M49.75M
Gross Margin18.20%19.47%18.75%18.77%21.02%20.19%21.32%19.67%20.04%21.85%24.17%29.94%29.52%28.79%28.29%28.06%28.78%27.87%27.56%25.78%21.75%21.03%
Operating Expense1.90M2.59M1.63M1.26M2.30M2.24M2.91M1.90M2.49M2.44M2.46M6.03M6.51M3.03M3.10M3.65M2.79M3.54M2.78M1.25M2.50M2.01M
Operating Income9.14M9.80M11.01M12.06M13.42M14.24M16.61M17.19M19.31M22.34M25.23M27.95M31.39M34.30M38.92M40.85M46.65M50.27M56.23M55.41M44.64M47.74M
Operating Margin15.07%15.40%16.34%16.99%17.94%17.44%18.14%17.71%17.76%19.70%22.02%24.63%24.45%26.46%26.21%25.76%27.16%26.04%26.26%25.21%20.59%20.18%
EBITDA9.71M10.75M12.09M13.36M15.10M16.08M18.60M19.14M27.24K25.16M27.75M30.91M34.85M38.54M44.12M48.29M55.66M61.59M68.53M68.63M59.44M65.30M
EBITDA Margin16.01%16.90%17.94%18.82%20.18%19.70%20.31%19.72%0.03%22.19%24.22%27.24%27.15%29.72%29.72%30.46%32.41%31.90%32.01%31.23%27.42%27.60%
Net Income5.01M5.68M7.30M8.02M8.89M9.40M10.72M11.75M13.52M15.82M17.01M18.79M20.57M23.20M25.43M28.40M30.71M39.12M46.25M47.05M36.23M39.31M
Net Income Margin8.26%8.92%10.84%11.30%11.88%11.52%11.71%12.11%12.43%13.95%14.85%16.56%16.02%17.89%17.13%17.91%17.88%20.26%21.60%21.41%16.72%16.62%
R&D------1.68M2.50M3.05M2.79M-3.67M3.71M648.00K--3.86K6.68K6.55M6.56M6.88M-
R&D as % of Total Revenue------1.84%2.57%2.81%2.46%-3.23%2.89%0.50%--0.00%0.00%3.06%2.99%3.17%-
Interest Expense177.00K127.00K439.00K620.00K615.00K270.00K163.00K117.00K71.00K150.00K159.00K159.00K110.00K218.00K294.00K414.00K571.00K589.00K679.00K669.00K1.10M1.09M
Interest Expense % of Total Revenue0.29%0.20%0.65%0.87%0.82%0.33%0.18%0.12%0.07%0.13%0.14%0.14%0.09%0.17%0.20%0.26%0.33%0.31%0.32%0.30%0.51%0.46%

Balance Sheet

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets51.15M55.17M66.75M70.02M78.07M79.58M84.21M90.86M101.91M109.41M113.55M123.98M150.70M178.16M223.81M258.10M295.78M329.95M400.28M394.05M398.01M439.12M
Total Liabilities26.26M27.14M37.15M36.23M39.45M35.34M33.16M32.36M34.98M33.34M31.86M32.42M47.04M73.24M106.76M126.19M146.82M164.72M154.01M166.42M157.32M176.00M
Total Equity22.42M25.23M29.16M33.24M37.97M43.63M50.33M57.74M16.55K75.64M81.34M90.65M23.60K26.23K28.47K35.92K37.52K50.51K189.78M251.85M231.51M252.35M
Cash17.78M2.54M1.90M1.50M1.90M2.77M4.06M6.03M6.18M16.09M12.47M13.95M32.25K27.58M32.57M24.18K37.38K41.41K26.74M21.17M19.32M34.13M
Total Debt7.33M6.11M15.62M17.09M17.85M10.25M7.11M4.84M3.35M2.48M1.57M1.58M10.40M16.88M43.19M57.48M71.81M84.06M66.71M69.27M58.55M53.85M
Net Debt7.33M3.56M13.72M15.60M15.96M7.48M3.04M-1.19M-2.83M-13.61M-10.90M-12.37M10.37M-10.70M10.62M57.45M71.78M84.02M39.97M48.10M39.23M19.72M

Cash Flow

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.19M10.37M5.02M8.20M7.64M20.56M12.68M14.92M19.25M13.51M12.96M21.15M23.89M28.63M29.63M42.60M48.55M48.44M58.59M61.59M52.55M60.71M
Investing Cash Flow-8.65M-1.96M-15.70M-5.55M-2.42M-2.42M-2.90M-2.98M-2.60M-2.54M-2.56M-4.29M-8.54M-18.48M-19.42M-33.10M-39.14M-36.19M-18.34M-50.53M-20.78M-24.20M
Financing Cash Flow-3.02M-4.91M4.75M-6.27M-5.05M-7.75M-13.27M-7.63M-14.53M-6.63M-12.79M-15.40M-1.71M-5.47M-4.82M-19.94M2.82M-10.72M-39.88M-16.09M-34.31M-18.34M
Capital Expenditure8.79M499.00K347.00K1.25M1.99M2.08M681.00K530.00K1.41M788.90K608.91K4.66M6.02M7.70M11.07M17.01M19.67M10.42M10.23M18.42M3.03M1.87M
Free Cash Flow-595.00K9.87M4.68M6.96M5.64M18.49M12.00M14.39M17.84M9.43M12.35M16.49M17.87M20.92M18.56M25.59M28.87M38.02M48.36M43.17M49.52M58.84M
Dividends Paid3.20M3.61M3.94M3.81M4.14M4.27M4.43M4.52M5.45M5.30M5.89M8.69M8.98M9.73M11.21M12.76M13.55M14.27M15.76M17.29M18.79M18.79M
FCF to OCF-7.26%95.19%93.09%84.82%73.89%89.90%94.63%96.45%92.68%69.80%95.30%77.97%74.80%73.09%62.64%60.07%59.48%78.48%82.55%70.10%94.23%96.91%
Dividend Paid to FCF-537.14%36.60%84.31%54.71%73.32%23.11%36.95%31.38%30.51%56.18%47.67%52.66%50.28%46.51%60.41%49.87%46.92%37.54%32.58%40.05%37.95%31.93%

Earnings

Report DateSep 28, 2026Apr 1, 2027
EPS Estimate--
EPS Actual--
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap580.54M
Enterprise Value466.48M
Trailing P/E0.12
Forward P/E0.00
Price / Sales2.58
Price / Book0.00
EPS2.58
Book Value16.78
Revenue (TTM)236.52M
Gross Profit (TTM)67.31M
EBITDA51.68M
Profit Margin16.63%
Operating Margin22.17%
Return on Equity16.31%
Return on Assets7.13%
Shares Outstanding14.95M
Shares Float4.89M
Beta0.56
Dividend Yield2.60%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
1.40Jul 1, 2026
20251×
1.25Jul 2, 2025
20241×
1.25Jul 2, 2024
20231×
1.15Jul 3, 2023
20221×
1.05Jun 30, 2022
20211×
0.95Jul 1, 2021
20201×
0.90Jul 1, 2020
20191×
0.85Jul 1, 2019
20181×
0.75Jul 2, 2018
20171×
0.65Jun 29, 2017
20161×
0.60Jun 30, 2016
20151×
0.58Jul 1, 2015
20141×
0.50Jul 1, 2014

Stock Splits

  • Aug 5, 20155:1